OrbiMed
OrbiMed is a global investment firm focused exclusively on the healthcare industry, investing in companies engaged in biopharmaceuticals, medical technologies, medical devices, diagnostics, drug discovery tools, and healthcare IT and services. It invests across the healthcare industry from seed-stage venture capital to large publicly-traded companies, through public equity, private equity, and private credit/royalty strategies.
Our funding tracker holds 2 rounds with OrbiMed, leading 2, across 2 companies; the latest is TruNativ (Not disclosed, $30 million, June 2026). Its website lists 22 portfolio companies.
What OrbiMed invests in
- Biopharmaceutical
- Medical Device
- Diagnostics/Tools
- Healthcare IT
- Healthcare Services
- Medical technologies
- Drug discovery tools
Stages: Seed, Start-ups, Growth equity, Commercial-stage, Publicly-traded companies.
Portfolio
- Acutus Medical
- ADARx Pharmaceuticals
- Adcendo
- Adela
- Adicet Bio
- Advanced Enzymes
- AER Therapeutics
- Aerin Medical
- AirNexis Therapeutics
- AirStrip
- AK Medical
- Alentis Therapeutics
- Alpheus Medical
- Alterome Therapeutics
- Altis Labs
- Alumis
- Avenzo Therapeutics
- Biokin
- Insmed Incorporated
- Mirador Therapeutics
- Perfuse
- Treeline Biosciences
Rounds in our tracker
| Date | Company | Round | Amount | Role |
|---|---|---|---|---|
| 16 Jun 2026 | TruNativ |
Not disclosed | $30 million | Lead |
| 14 Jan 2026 | Pee Safe |
Not disclosed | $32 million | Lead |
Deals by category and stage
Categories
- Health & Wellness
- Food & Beverages
- Beauty & Personal Care
Stages
- Not disclosed
Frequently asked questions
What is OrbiMed?
OrbiMed is a global investment firm focused exclusively on the healthcare industry, investing in companies engaged in biopharmaceuticals, medical technologies, medical devices, diagnostics, drug discovery tools, and healthcare IT and services. It invests across the healthcare industry from seed-stage venture capital to large publicly-traded companies, through public equity, private equity, and private credit/royalty strategies.
Which brands has OrbiMed invested in?
Including TruNativ, Pee Safe, Acutus Medical, ADARx Pharmaceuticals, Adcendo, Adela, Adicet Bio, Advanced Enzymes, AER Therapeutics, Aerin Medical, AirNexis Therapeutics, AirStrip.
What does OrbiMed invest in?
Biopharmaceutical, Medical Device, Diagnostics/Tools, Healthcare IT, Healthcare Services, Medical technologies, Drug discovery tools, at seed, start-ups, growth equity, commercial-stage, publicly-traded companies stage, as stated on its website.
What is OrbiMed's latest investment?
TruNativ, Not disclosed of $30 million, announced in June 2026.
Profile
- Type
- Venture capital
- Based in
- New York City
- Founded
- 1989
- Assets under management
- $21B
- Portfolio Companies
- 500+
- Total Professionals
- 150+
- Global Locations
- 12
- Venture-backed IPOs
- 130+
- Website
- orbimed.com
Checked against the official website on 13 Nov 2026.
Are you OrbiMed?
Send portfolio announcements or correct a detail, and we will update this page and the funding tracker.
Send an announcement